TY  - GEN
AU  - Hou,Feng-Qin
AU  - Song,Liu-Wei
AU  - Yuan,Quan
AU  - Fang,Lin-Lin
AU  - Ge,Sheng-Xiang
AU  - Zhang,Jun
AU  - Sheng,Ji-Fang
AU  - Xie,Dong-Ying
AU  - Shang,Jia
AU  - Wu,Shu-Huan
AU  - Sun,Yong-Tao
AU  - Wei,Shao-Feng
AU  - Wang,Mao-Rong
AU  - Wan,Mo-Bin
AU  - Jia,Ji-Dong
AU  - Luo,Guang-Han
AU  - Tang,Hong
AU  - Li,Shu-Chen
AU  - Niu,Jun-Qi
AU  - Zhou,Wei-Dong
AU  - Sun,Li
AU  - Xia,Ning-Shao
AU  - Wang,Gui-Qiang
TI  - Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon
SN  - 1838-7640
PY  - 2015///0831
KW  - Adult
KW  - Biomarkers
KW  - blood
KW  - DNA, Viral
KW  - Drug Monitoring
KW  - methods
KW  - Female
KW  - Hepatitis B Antibodies
KW  - Hepatitis B Core Antigens
KW  - immunology
KW  - Hepatitis B e Antigens
KW  - Hepatitis B, Chronic
KW  - diagnosis
KW  - Humans
KW  - Interferon-alpha
KW  - therapeutic use
KW  - Male
KW  - Middle Aged
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.7150/thno.10636
ER  -